Predicting Scientific Success

A scientist’s most influential paper may come at any point in her career but chances are it won’t change her overall success, researchers show.

Written byRuth Williams
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, ROBERT CUDMOREIrrespective of whether a scientist reaches the peak of her career early or late in life, the overall impact of her papers remains relatively steady, according to a study published in Science today (November 3). This consistent impact level—or Q value—can be determined with as few as 10 papers, and used to predict a scientist’s future achievements, according to the authors.

“It has been suggested that you’re more creative when you’re young, so you can expect to have your highest impact [paper] when you’re younger, but actually what the [researchers] show is that people can produce their highest impact work at any stage of their individual careers, as long as they are productive,” said Stasa Milojevic an informatician at Indiana University in Bloomington who was not involved in the work. “I think, for most people, that would be encouraging [because] until the very last paper, there is hope.”

On the other hand, Milojevic added, the finding that a researcher’s impact is stable, “is a bit more negative,” meaning that if an early-career scientist’s Q value is low, they are unlikely to have a really big impact ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies